medigraphic.com
ISSN 1561-3127 (Electronic)
ISSN 0864-3466 (Print)

2013, Number 4

<< Back Next >>

Revista Cubana de Salud Pública 2013; 39 (4)

Risk factors for occurrence of acute myocardial infarction in smokers patients

González PJA, González PJM

Language: Spanish
References: 20
Page:
PDF size: 150.91 Kb.


ABSTRACT

Introduction: cardiovascular diseases are the main causes of death in many countries.
Objective: to evaluate the occurrence of acute myocardial infarction in smoking patients in a Venezuelan population section.
Methods: a case-control study was carried out with a randomly selected sample of 70 cases and 70 controls. Sociodemographic and premorbid factors as well as toxic habits were studied. The statistical analysis was based on univariate strategy with odd ratios estimated for every hypothetically influential risk factor and their confidence intervals of 95 %. Finally, a multivariate study determined the independent value of each risk factor.
Results: in the univariate analysis, all factors represented a risk for the onset of acute myocardial infarction. Hypercholesterolemia was the main risk factor in the multivariate analysis, since it increased the risk of myocardial infarction by 4.2 times (OR 4.20 CI 1.18- 14.97), followed by the length of the smoking habit (OR 3.60 CI 1.46 8.91) and the quantity of cigarettes smoked daily (OR 2.32; IC 1.02 4.95).
Conclusions: hypercholesterolemia has greater effect on possible occurrence of myocardial infarction than the rest of risk factors studied in smoking patients; therefore it is the most significant factor.


REFERENCES

  1. Anderson JL, Adams CD, Antman EM, Bridges CR, Casey DE, Chavey WE, et al. ACC/AHA 2009 Guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;116:e148-e304.

  2. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 19902020: global burden of disease study. Lancet .2008;349:1498504.

  3. Elliot M, Braunwald E. Infarto Agudo de Miocardio. En: Elphid FL, editor. Harrison. Principios de Medicina Interna. 15à ed. Madrid: McGraw-Hill Interamericana de España; 2006. p.1629

  4. Delcán JL. Cardiopatía Isquémica. Epidemiología de la Cardiopatía Isquémica: Factores de Riesgo y Prevención Primaria. Madrid: Salvat ediciones; 2006.

  5. Bertomeu V, Quiles J. La cardiopatía isquémica en atención primaria: ¿conocemos la magnitud del problema y actuamos en consecuencia? Rev Esp Cardiol. 2009;58:338- 40.

  6. Roger VL. Epidemiology of myocardial infarction. Med Clin North Am. 2009;91(4):537.

  7. Mendoza Espinoza MJ. Características Clínicas y Epidemiológicas de los pacientes diabéticos con Infarto Agudo del Miocardio ingresado al Servicio de Cardiología de Medicina Interna. Enero 2001-diciembre 2003. 2004 [citado 24 Ene 2010]. Disponible en: http://www.minsa.gob.ni/bns/monografias/Full_text/medicina_interna/carac_clinic a_epidemiologicas.PDF

  8. Kliver M, Berman S, Muntaner J, Herrera R, Luciardi H. Epidemiología y factores de riesgo. [citado 24 Ene 2010]. Disponible en: http://www.sac.org.ar/rac/2003/v4_b/cg- 1.pdf

  9. Velázquez-Monroy O, Rosas Peralta M, Lara Esqueda A, Pastelín Hernández G, Castillo C, Attie F, et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México: resultados finales de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex. 2009;73:62-77.

  10. De Backer G, Ambrosioni E, Borch-Johnsem K, Brotons C, Cifkova R, Dallongaville J, et al. Third Joint Task Force of European and other Societies on Cardiovascular Diseases Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardio Prev Rev. 2009;10 Suppl 1:1-78.

  11. Kozarevic D, Mc Gee D, Vajvodic N. Frequency of alcohol consumption and mortality. Lancet. 2008;1:613-6.

  12. Kagan A, Yano K, Rhoads GG. Alcohol and cardiovascular disease. The Hawaiian experience. Circulation. 2009;64 Suppl 3:27-31.

  13. Keys A, Anderson JT, Grande F. Lipids and coronary heart disease. Endocrinology and Metabolism. Med Clin North Am. 2009;19:321-3.

  14. Cuspidi C, Valerio C, Sala C, Negri F, Esposito A, Masaidi M, et al. Metabolic syndrome and biventricular hypertrophy in essential hypertension. J Hum Hypertens. 2009;23(3):16875.

  15. González-Diego P, Moreno-Iribas C, Guembe MJ, Viñes JJ, Vila J. Adaptación de la función de riesgo coronario de Framingham-Wilson para la población de Navarra (RICORNA). Rev Esp Cardiol. 2009;62(8):875-85.

  16. US Dept of Health and Human Services. Reducing the Health Consequences of Smoking: 25 Years of Progress. DHHS Publication (CDC) 89-8411. Atlanta: Centers for Disease Control; 2009.

  17. Wilson PWF. Overweight and obesity as determinants of cardiovascular risk. The Framingham experience. Arch Internat Med. 2009;162:1867-72.

  18. Jousilahti P. Body weigh, cardiovascular risk factors, and coronary mortality. 15 year follow-up of middle-aged men and women in eastern Finland. Circulation. 2008;93:1372-9.

  19. Ockene JK, Kuller LH, Svendsen KH. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Interventional Trial (MRFIT). Am J Public Health. 1990;80:954-8.

  20. Sparrow D, Dawber TR. The influence of cigarette smoking on prognosis after a first myocardial infarction: a report from the Framingham Study. J Chronic Dis. 1978;31:425-32.




2020     |     www.medigraphic.com